1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow Heart Failure, Reduced Ejection Fraction: new trials by email Literature Review of Heart Failure, Reduced Ejection Fraction trials Research Report on Heart Failure, Reduced Ejection Fraction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes Ketone Monoester (KE) - Type 2 Diabetes, Heart Failure, Reduced Ejection Fraction | Early Phase 1 | Recruiting | The University of Texas Health Science Center at San Antonio | 10 | 2024-01-16 | 2026-01-21 |
Diabetes Mellitus, Type 2 (1) · Heart Failure, Systolic (1)
Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Heart Failure (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
rVSV-deltaG-spike COVID-19 vaccine (1)
The University of Texas Health Science Center at San Antonio (1)
United States (1)
Carolina Solis-Herrera, MD (1)
1UM1TR004538-01 (1)